Literature DB >> 17046737

A critical role for the EphA3 receptor tyrosine kinase in heart development.

Lesley J Stephen1, Amy L Fawkes, Adam Verhoeve, Greg Lemke, Arthur Brown.   

Abstract

Eph proteins are receptor tyrosine kinases that control changes in cell shape and migration during development. We now describe a critical role for EphA3 receptor signaling in heart development as revealed by the phenotype of EphA3 null mice. During heart development mesenchymal outgrowths, the atrioventricular endocardial cushions, form in the atrioventricular canal. This morphogenetic event requires endocardial cushion cells to undergo an epithelial to mesenchymal transformation (EMT), and results in the formation of the atrioventricular valves and membranous portions of the atrial and ventricular septa. We show that EphA3 knockouts have significant defects in the development of their atrial septa and atrioventricular endocardial cushions, and that these cardiac abnormalities lead to the death of approximately 75% of homozygous EphA3(-/-) mutants. We demonstrate that EphA3 and its ligand, ephrin-A1, are expressed in adjacent cells in the developing endocardial cushions. We further demonstrate that EphA3(-/-) atrioventricular endocardial cushions are hypoplastic compared to wildtype and that EphA3(-/-) endocardial cushion explants give rise to fewer migrating mesenchymal cells than wildtype explants. Thus our results indicate that EphA3 plays a crucial role in the development and morphogenesis of the cells that give rise to the atrioventricular valves and septa.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17046737     DOI: 10.1016/j.ydbio.2006.08.058

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  30 in total

Review 1.  Therapeutic targeting of EPH receptors and their ligands.

Authors:  Andrew W Boyd; Perry F Bartlett; Martin Lackmann
Journal:  Nat Rev Drug Discov       Date:  2014-01       Impact factor: 84.694

2.  Cancer somatic mutations disrupt functions of the EphA3 receptor tyrosine kinase through multiple mechanisms.

Authors:  Erika M Lisabeth; Carlos Fernandez; Elena B Pasquale
Journal:  Biochemistry       Date:  2012-02-08       Impact factor: 3.162

Review 3.  Eph-dependent cell-cell adhesion and segregation in development and cancer.

Authors:  Eva Nievergall; Martin Lackmann; Peter W Janes
Journal:  Cell Mol Life Sci       Date:  2011-12-28       Impact factor: 9.261

Review 4.  Eph receptors and ephrins: therapeutic opportunities.

Authors:  Antonio Barquilla; Elena B Pasquale
Journal:  Annu Rev Pharmacol Toxicol       Date:  2014-10-03       Impact factor: 13.820

Review 5.  What chick and mouse models have taught us about the role of the endocardium in congenital heart disease.

Authors:  Daniel M DeLaughter; Leshana Saint-Jean; H Scott Baldwin; Joey V Barnett
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2011-04-28

6.  Regulation of heart valve morphogenesis by Eph receptor ligand, ephrin-A1.

Authors:  Leslie A Frieden; Todd A Townsend; David B Vaught; Daniel M Delaughter; Yoonha Hwang; Joey V Barnett; Jin Chen
Journal:  Dev Dyn       Date:  2010-10-19       Impact factor: 3.780

Review 7.  Mechanisms of tissue fusion during development.

Authors:  Heather J Ray; Lee Niswander
Journal:  Development       Date:  2012-05       Impact factor: 6.868

8.  Treatment with ephrin B2 positively impacts the abnormal metabolism of human osteoarthritic chondrocytes.

Authors:  Steeve Kwan Tat; Jean-Pierre Pelletier; Nathalie Amiable; Christelle Boileau; Martin Lavigne; Johanne Martel-Pelletier
Journal:  Arthritis Res Ther       Date:  2009-08-07       Impact factor: 5.156

9.  Structural recognition of an optimized substrate for the ephrin family of receptor tyrosine kinases.

Authors:  Tara L Davis; John R Walker; Abdellah Allali-Hassani; Sirlester A Parker; Benjamin E Turk; Sirano Dhe-Paganon
Journal:  FEBS J       Date:  2009-08       Impact factor: 5.542

Review 10.  Regulation of tumor initiation and metastatic progression by Eph receptor tyrosine kinases.

Authors:  Jin Chen
Journal:  Adv Cancer Res       Date:  2012       Impact factor: 6.242

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.